Cover Image

Overexpression of KCNJ2 in induced pluripotent stem cell-derived cardiomyocytes for the assessment of QT-prolonging drugs

Human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes hold great potentials to predict pro-arrhythmic risks in preclinical cardiac safety screening, although the hiPSC cardiomyocytes exhibit rather immature functional and structural characteristics, including spontaneous activity. Our p...

Full description

Saved in:

Bibliographic Details
Main Authors:	Min Li (Author), Yasunari Kanda (Author), Takashi Ashihara (Author), Tetsuo Sasano (Author), Yuji Nakai (Author), Masami Kodama (Author), Erina Hayashi (Author), Yuko Sekino (Author), Tetsushi Furukawa (Author), Junko Kurokawa (Author)
Format:	Book
Published:	Elsevier, 2017-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Systematic expression analysis of genes related to generation of action potentials in human iPS cell-derived cardiomyocytes
by: Masami Kodama, et al.
Published: (2019)

Electrophysiological analyses of transgenic mice overexpressing KCNJ8 with S422L mutation in cardiomyocytes
by: Yasuhiro Watanabe, et al.
Published: (2017)

Development of correction formula for field potential duration of human induced pluripotent stem cell-derived cardiomyocytes sheets
by: Hiroko Izumi-Nakaseko, et al.
Published: (2017)

Application of human induced pluripotent stem cell-derived cardiomyocytes sheets with microelectrode array system to estimate antiarrhythmic properties of multi-ion channel blockers
by: Hiroko Izumi-Nakaseko, et al.
Published: (2018)

Proarrhythmia risk prediction using human induced pluripotent stem cell-derived cardiomyocytes
by: Daiju Yamazaki, et al.
Published: (2018)

A Receptor-Independent Effect of Estrone Sulfate on the hERG Channel
by: Shoko Kakusaka, et al.
Published: (2009)

Assessment of Testing Methods for Drug-Induced Repolarization Delay and Arrhythmias in an iPS Cell-Derived Cardiomyocyte Sheet: Multi-site Validation Study
by: Yuji Nakamura, et al.
Published: (2014)

A distribution analysis of action potential parameters obtained from patch-clamped human stem cell-derived cardiomyocytes
by: Fernando López-Redondo, et al.
Published: (2016)

Development of torsadogenic risk assessment using human induced pluripotent stem cell-derived cardiomyocytes: Japan iPS Cardiac Safety Assessment (JiCSA) update
by: Yasunari Kanda, et al.
Published: (2018)

New Aspects for the Treatment of Cardiac Diseases Based on the Diversity of Functional Controls on Cardiac Muscles: Acute Effects of Female Hormones on Cardiac Ion Channels and Cardiac Repolarization
by: Junko Kurokawa, et al.
Published: (2009)

miR-199a Overexpression Enhances the Potency of Human Induced-Pluripotent Stem-Cell-Derived Cardiomyocytes for Myocardial Repair
by: Weihua Bian, et al.
Published: (2021)

Effects of Antiarrhythmic Drugs on hERG Gating in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
by: Mengying Huang, et al.
Published: (2021)

Deep learning-based quality control of cultured human-induced pluripotent stem cell-derived cardiomyocytes
by: Ken Orita, et al.
Published: (2019)

Possible effects of inhibition of IKr and IKs on field-potential waveforms in the human iPS cell-derived cardiomyocytes sheet
by: Junko Matsuo, et al.
Published: (2015)

In vitro effect of hydroxychloroquine on pluripotent stem cells and their cardiomyocytes derivatives
by: Michelle Vanessa Kamga Kapchoup, et al.
Published: (2023)

Mitochondrial Maturation in Human Pluripotent Stem Cell Derived Cardiomyocytes
by: Dao-Fu Dai, et al.
Published: (2017)

Ionic Mechanisms of Disopyramide Prolonging Action Potential Duration in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
by: Huan Lan, et al.
Published: (2020)

Stretch of Atrial Myocytes Stimulates Recruitment of Macrophages via ATP Released Through Gap-Junction Channels
by: Sakiko Oishi, et al.
Published: (2012)

Overexpression of PEP-19 Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy
by: Yang-yang Xie, et al.
Published: (2014)

Global RNA editing identification and characterization during human pluripotent-to-cardiomyocyte differentiation
by: Juan Chen, et al.
Published: (2021)

Electrophysiological Characterization of Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
by: Masaki Honda, et al.
Published: (2011)

Extracellular Recordings of Patterned Human Pluripotent Stem Cell-Derived Cardiomyocytes on Aligned Fibers
by: Junjun Li, et al.
Published: (2016)

Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
by: Zhihan Zhao, et al.
Published: (2018)

QT PRODACT: In Vivo QT Assay in the Conscious Dog for Assessing the Potential for QT Interval Prolongation by Human Pharmaceuticals
by: Shigeki Toyoshima, et al.
Published: (2005)

KCNJ14 knockdown significantly inhibited the proliferation and migration of colorectal cells
by: Bin Li, et al.
Published: (2022)

Andersen-Tawil Syndrome With Novel Mutation in KCNJ2: Case Report
by: Jisook Yim, et al.
Published: (2022)

Aminophylline Induces Two Types of Arrhythmic Events in Human Pluripotent Stem Cell-Derived Cardiomyocytes
by: Simon Klimovic, et al.
Published: (2022)

Metabolism of human pluripotent stem cells and differentiated cells for regenerative therapy: a focus on cardiomyocytes
by: Sho Tanosaki, et al.
Published: (2021)

KCNJ15 deficiency promotes drug resistance via affecting the function of lysosomes
by: Xinbo Qiao, et al.
Published: (2023)

QT PRODACT: In Vivo QT Assay With a Conscious Monkey for Assessment of the Potential for Drug-Induced QT Interval Prolongation
by: Kentaro Ando, et al.
Published: (2005)

Initial Characterization of Stressed Transgenic Mice With Cardiomyocyte-Specific Overexpression of Protein Phosphatase 2C
by: Paula Bollmann, et al.
Published: (2021)

In vitro maturation of human pluripotent stem cell-derived cardiomyocyte: A promising approach for cell therapy
by: Yun-Gwi Park, et al.
Published: (2022)

Electrophysiological Changes of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes during Acute Hypoxia and Reoxygenation
by: Martta Häkli, et al.
Published: (2022)

Structural and Mechanistic Bases of Nuclear Calcium Signaling in Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes
by: Sen Li, et al.
Published: (2019)

QT PRODACT: Usability of Miniature Pigs in Safety Pharmacology Studies: Assessment for Drug-Induced QT Interval Prolongation
by: Mayumi Kano, et al.
Published: (2005)

Human‐induced pluripotent stem cell‐derived cardiomyocytes: Cardiovascular properties and metabolism and pharmacokinetics of deuterated mexiletine analogs
by: Jorge Gomez‐Galeno, et al.
Published: (2021)

Divergent effects of adrenaline in human induced pluripotent stem cell-derived cardiomyocytes obtained from hypertrophic cardiomyopathy
by: Chandra Prajapati, et al.
Published: (2018)

Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich's ataxia
by: Aurore Hick, et al.
Published: (2013)

Association Between KCNJ6 (GIRK2) Gene Polymorphism rs2835859 and Post-operative Analgesia, Pain Sensitivity, and Nicotine Dependence
by: Daisuke Nishizawa, et al.
Published: (2014)

Investigation of KCNJ11 Gene Variant (rs 5219) in Patients with Diabetes after Liver Transplantation
by: Zahra Parvizi, et al.
Published: (2014)